BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
BillionToOne, Inc.NASDAQ: BLLN
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables rises 146.1% from a year ago
Net receivables stood at $74.89M at the end of Q2 FY2026, up 146.1% from a year earlier and up 22.2% from the prior quarter.
Context
- Net receivables amounted to 10.3% of total assets at the end of Q2 FY2026, up 0.5 pp from a year earlier.
- Net receivables increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +146.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 41.62M USD
- Year-over-year change
- +68.4%
- 2-year CAGR
- +114.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 41.62M | +68.4% |
| FY2024 | 2024-12-31 | 24.71M | +171.8% |
| FY2023 | 2023-12-31 | 9.09M | — |
Net Receivables vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 net receivables of $74.89M is the 7th highest of the 9 companies compared; the peer median is $103.71M.
- Its year-over-year change of +146.1% is the highest of 9, against a peer median of +17.4%.
- Net receivables amounts to 10.3% of total assets for BLLN, versus a peer median of 11.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $421.97M | +36.5% | +6.7% | 15.9% | |
| Sep 2026 | $186.55M | +61.4% | +12.3% | 9.9% | |
| Jun 2026 | $175.41M | +14.2% | +10.0% | 13.0% | |
| Mar 2026 | $123.8M | +2.8% | +4.3% | 18.4% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $83.61M | +74.1% | +19.7% | 17.4% |
| Mar 2026 | $75.74M | -5.8% | +6.8% | 6.5% | |
BLLNBillionToOne, Inc. | Jun 2026 | $74.89M | +146.1% | — | 10.3% |
| Jun 2026 | $54.18M | +6.6% | +0.5% | 3.6% | |
| Jun 2026 | $19.76M | +20.6% | -0.6% | 0.7% | |
| Peer median (excluding BLLN) | $103.71M | +17.4% | +6.8% | 11.4% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.